Navigation Links
Lab tests show arthritis drug effective against global parasite
Date:5/20/2012

throughput screen that could be conducted in an oxygen-free, or anaerobic, environment, to mimic the amoeba's natural environment. Debnath was working at the time with Reed's lab, at UC San Diego, studying the impact of protease inhibitors on amebiasis, and realized he needed to be able to screen thousands of compounds.

Because of the need for an oxygen-free environment, most tests on amoebas are conducted in small batches, testing one or two compounds at a time. The modern approach to these tests conducting thousands of screens at once had never been done in an anaerobic environment. So Debnath reached out to the UCSF Small Molecule Discovery Center in the UCSF School of Pharmacy and QB3, which uses technology from the pharmaceutical industry to help bioscience researchers screen the targets they discover against potential therapies. Together, they modified the standard screen so it could be used in an anaerobic environment.

The second lucky stroke was a call McKerrow received during the project from Iconix Biosciences, a Menlo Park, CA, company that was going out of business. Iconix offered the Sandler Center its screening library of 900 compounds each in its own vial that have been approved by the FDA for human use.

With more than half of the FDA-approved compounds at their disposal, the team worked with the Small Molecule Discovery Center to screen the drugs against amoebas.

The results were startling: The drug was 10 times more potent in the screens against E. histolytica than the current treatment.

"The top hit was this drug auranofin, which caught our attention for a couple of reasons," McKerrow said. "First, it was more effective than the current drug, and importantly, it was a drug that has been given to people since 1985. So we knew it could be taken orally and was safer than the current drug for amoebas."

Beyond the Lab

Thus, they knew they had a safe drug that was effectiv
'/>"/>

Contact: Kristen Bole
kristen.bole@ucsf.edu
415-502-6397
University of California - San Francisco
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Dip chip technology tests toxicity on the go
2. VolitionRX Raises Over $1 Million To Begin Clinical Trials of Blood Based Diagnostic Tests
3. UC research tests new tool to guide reintroduction of the American chestnut
4. PETA launches in silico testing resource to reduce number of animal tests
5. Kessler Foundation tests Ekso exoskeletal device in 6 patients with traumatic spinal cord injury
6. University Hospitals Seidman Cancer Center tests novel drug that makes brain tumors glow hot pink
7. Maryland climate plan passes key tests in UMD studies
8. Combination HPV diagnostic test for head and neck cancer outperformed other tests
9. Berkeley Lab tests cookstoves for Haiti
10. New UNH data tests the exercise talk test
11. Nanosensors made from DNA may light path to new cancer tests and drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2014)... , Dec. 9, 2014  Wake Forest Baptist Medical Center ... for its School of Medicine. Funding for this $50 ... campaign that will be publicly launched next summer. ... in the former 60 series R.J. Reynolds Tobacco Company ... Construction will begin immediately with plans to be ready ...
(Date:12/10/2014)... , Dec. 08, 2014 Research and Markets ... addition of the "Biometrics Market in Japan ... http://photos.prnewswire.com/prnh/20130307/600769 The ... such as rural banking and upgradation of the ... witnessed in the market. Besides the aforementioned projects, ...
(Date:12/5/2014)... 2014 Increased emphasis on product quality, ... testing and inspection technologies. The convergence of industries ... range of innovative test solutions. This trend is ... which is generally more inclined towards communication, media ... strategies of test equipment vendors will cater to ...
Breaking Biology News(10 mins):Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4
... of the American Medical Society ("Medical News & ... Associate Professor Sergei Adamovich, a biomedical engineer. Adamovich and ... and Eugene Tunik, PhD, PT, at the University of ... robotic and virtual reality-based video game therapies to help ...
... that the animal with the most genes--about 31,000--is the ... By comparison, humans have about 23,000 genes. Daphnia is ... The water flea,s genome is described in a ... the Daphnia Genomics Consortium, an international network of scientists ...
... provided the first conclusive evidence that cannabis use significantly hastens ... brain development with possible life-long consequences. The ... smoking cannabis is associated with an earlier onset of psychotic ... an international team including Dr Matthew Large, from the University ...
Cached Biology News:JAMA features NJIT biomedical engineer helping stroke patients 2JAMA features NJIT biomedical engineer helping stroke patients 3The most genes in an animal? Tiny crustacean holds the record 2The most genes in an animal? Tiny crustacean holds the record 3Cannabis linked to earlier onset of psychosis 2
(Date:12/24/2014)... 24, 2014  Vermillion, Inc. (Nasdaq:   VRML), ... announced today that the Company closed its previously ... Management, Jack W. Schuler , Birchview Fund ... $10.5 million, before offering expenses.  The proceeds will ... purposes. Under the terms of the ...
(Date:12/24/2014)... December 23, 2014 ... is designed to introduce cutting edge communication ... and partners of platform upgrades. This webinar ... empowering users in their quest to leverage ... , According to SoundConnect’s Marketing Manager, Seanna ...
(Date:12/24/2014)... The report expects global cell isolation and expansion ... provides a carefully analyzed data about the vital drivers, ... , Full Copy of Report @ http://bit.ly/1yUxy0T ... cell expansion will keep witnessing growth at an impressive ... be driven by rapid technological advancements, government funding and ...
(Date:12/24/2014)... , Dec. 23, 2014 Sigma-Aldrich ... that the waiting period under the Hart-Scott-Rodino Antitrust ... acquisition expired on December 22, 2014, thereby completing ... requirement for the acquisition of the Company by ... antitrust clearance satisfies another condition to closing the ...
Breaking Biology Technology:Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3SoundConnect Launches Leading Edge Business Communications Webinar Series 2SoundConnect Launches Leading Edge Business Communications Webinar Series 3The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 2The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 3Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3
... NOVATO, Calif., Sept. 8 BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ... present a company update at the Morgan Stanley Healthcare Conference in New ... , , Interested parties may access a live ... BioMarin website, www.BMRN.com . A replay of the ...
... , NEW BRUNSWICK, N.J., Sept. 8 ... SNT ) today announced that the Company will be presenting at ... held at the New York Palace Hotel from September 9th - ... will deliver the Company,s corporate presentation on Friday, September 11th, at ...
... CAMBRIDGE, Massachusetts, September 8 Shire plc,(LSE: SHP, ... company, is,committed to doing everything possible to assist Gaucher ... is pleased to be,able to provide velaglucerase alfa well ... wide. , In the U.S., ...
Cached Biology Technology:BioMarin to Present at the Morgan Stanley Healthcare Conference 2Senesco Technologies to Present at 11th Annual Rodman & Renshaw Healthcare Conference 2Update on velaglucerase alfa 2Update on velaglucerase alfa 3
Goat polyclonal to NIR1 ( Abpromise for all tested applications). Antigen: Synthetic peptide: SWARGPPKFESVP, corresponding to C terminal amino acids 962-974 of NIR1. Entrez Gene ID: 83394 ...
HOXC11 Antibody...
Anti-MMP-14, catalytic domain, clone LEM-2/15.8 Immunogen: Synthetic peptide: amino acid sequence 218-233 within the catalytic domain Available Date: 38579...
Anti-MMP-19 (RASI), carboxy terminal region; rabbit host...
Biology Products: